Table 1.
Author | Country | Year | Type of study | Patients | Control | Cut off (pmol/L) | TP | FP | FN | TN | SEN | SPE |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Moore RG et al. [5] |
USA |
2008 |
prospective/retrospective |
171 |
156 |
/ |
78 |
8 |
93 |
148 |
46 |
95 |
Zanotti L et al. [6] |
Italy |
2012 |
retrospective |
193(152 + 41) |
125 |
51 |
152 |
19 |
41 |
106 |
79 |
85 |
|
|
|
|
|
|
64 |
127 |
6 |
66 |
119 |
66 |
95 |
Angioli R et al. [7] |
Italy |
2013 |
prospective |
101(95 + 6) |
103 |
70 |
60 |
0 |
41 |
103 |
59 |
100 |
|
|
|
|
|
|
150 |
36 |
0 |
65 |
103 |
36 |
100 |
Omer Bet al. [8] |
Turkey |
2013 |
prospective l |
64(54 + 10) |
94(60 + 34) |
60 |
48 |
32 |
16 |
62 |
75 |
66 |
Bignotti E et al. [9] |
Italy |
2011 |
prospective |
138(109 + 29) |
76 |
/ |
92 |
4 |
46 |
72 |
67 |
95 |
Zhang, Ai-min et al. [10] |
China |
2012 |
prospective |
124 |
206(97 + 109) |
/ |
51 |
10 |
73 |
196 |
41 |
95 |
Total | 791 | 760 |
Studies [6], [7], [8] and [9] included patients with different pathological types. The pathological types of patients in study [5] and study [10] are unclear. Studies [8] and [10] included people with uterine benign disease and had healthy people as controls. The controls of other studies are healthy.
FN, False Negative; FP, False Positive; SEN, Sensitivity; SPE, Specificity TN, True Negative; TP, True Positive.